Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs.
Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs. Its first practical and cost-effective platform, Hero Patch, delivers clinically meaningful doses of macromolecules such as monoclonal antibodies or small molecules for fast and sustained delivery.The company was founded in 2019 by Jake Lombardo, Konstantinos Tzortzakis, and Hojatollah Rezaei Nejad.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 3, 2021 | Seed | $4.20M | 3 | — | — | Detail |
Aug 7, 2020 | Seed | $2M | 2 | Velocity.Partners | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Relativity Healthcare Partners | — | Seed |
Big Pi | — | Seed |
Velocity.Partners | — | Seed |
Bantam Group | — | Seed |